See more : TTW Public Company Limited (TTW-R.BK) Income Statement Analysis – Financial Results
Complete financial analysis of LAVA Medtech Acquisition Corp. (LVACU) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of LAVA Medtech Acquisition Corp., a leading company in the Shell Companies industry within the Financial Services sector.
- Metaplanet Inc. (3350.T) Income Statement Analysis – Financial Results
- AVI Japan Opportunity Trust PLC (AJOT.L) Income Statement Analysis – Financial Results
- SSP Group plc (SSPG.L) Income Statement Analysis – Financial Results
- Tevogen Bio Holdings Inc. (TVGNW) Income Statement Analysis – Financial Results
- MPLX LP (MPLXP) Income Statement Analysis – Financial Results
LAVA Medtech Acquisition Corp. (LVACU)
Industry: Shell Companies
Sector: Financial Services
About LAVA Medtech Acquisition Corp.
LAVA Medtech Acquisition Corp. does not have significant operations. It intends to acquire assets and businesses through a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. The company focuses on pursuing opportunities in healthcare and healthcare-related industries. The company was incorporated in 2021 and is based in Waltham, Massachusetts. LAVA Medtech Acquisition Corp. is a subsidiary of LAVA Medtech Sponsor LP.
| Metric | 2022 | 2021 |
|---|---|---|
| Revenue | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 |
| General & Administrative | 1.30M | 204.24K |
| Selling & Marketing | 0.00 | 0.00 |
| SG&A | 1.30M | 204.24K |
| Other Expenses | 262.59K | 0.00 |
| Operating Expenses | 1.56M | 204.24K |
| Cost & Expenses | 1.56M | 204.24K |
| Interest Income | 1.71M | 0.00 |
| Interest Expense | 0.00 | -17.65M |
| Depreciation & Amortization | -4.66M | 17.65M |
| EBITDA | -6.22M | 17.95M |
| EBITDA Ratio | 0.00% | 0.00% |
| Operating Income | -1.56M | 297.46K |
| Operating Income Ratio | 0.00% | 0.00% |
| Total Other Income/Expenses | 6.37M | 17.65M |
| Income Before Tax | 4.81M | 17.95M |
| Income Before Tax Ratio | 0.00% | 0.00% |
| Income Tax Expense | 304.29K | -19.15K |
| Net Income | 4.50M | 17.97M |
| Net Income Ratio | 0.00% | 0.00% |
| EPS | 0.31 | 1.25 |
| EPS Diluted | 0.31 | 1.25 |
| Weighted Avg Shares Out | 14.37M | 14.37M |
| Weighted Avg Shares Out (Dil) | 14.37M | 14.37M |
Source: https://incomestatements.info
Category: Stock Reports